Corcept Therapeutics Incorporated (NASDAQ:CORT) Receives Consensus Recommendation of “Moderate Buy” from Brokerages

Shares of Corcept Therapeutics Incorporated (NASDAQ:CORT – Get Free Report) have been given an average recommendation of “Moderate Buy” by the seven research firms that are presently covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating on the company. The […]

Leave a Reply

Your email address will not be published.

Previous post CoStar Group (NASDAQ:CSGP) and 36Kr (NASDAQ:KRKR) Head-To-Head Comparison
Next post Beyond Meat, Inc. (NASDAQ:BYND) Receives Average Recommendation of “Strong Sell” from Brokerages